Molecular Testing in HR+/HER2- mBC

 

Molecular Testing in HR+/HER2- mBC
04:11

Mario Campone

Alpelisib + Fulvestrant for PIK3CAm HR+/HER2- Advanced BC: SOLAR-1 Trial Final OS Results

  • 441 views
  • February 23, 2022
  • 1
12:54

UCLA Health

Importance of Thoughtful Testing for PIK3CA Mutations in HR+ MBC

FEATURING Kelly McCann
  • 287 views
  • March 14, 2022
  • 1
19:43

2020 Best of Breast

Endocrinopathy Management Related to Oncologic Agents: Alpelisib and Hyperglycemia, Pembrolizumab and Hyperthyroidism

FEATURING Salila Kurra
  • 154 views
  • March 2, 2020
41:48

Association of Community Cancer Centers (ACCC)

Oral Agents for Advanced HR+ Breast Cancer

FEATURING Leigh Boehmer, Pavani Chalasani, Elizabeth Dow, Tammy Smith
  • 166 views
  • November 8, 2021
21:10

2022 West Oncology Conference

HR+ Breast Cancer: A Paradigm for Precision Oncology

FEATURING Lee Schwartzberg
  • 256 views
  • March 14, 2022
  • 1
26:04

University of Kansas Cancer Center Post San Antonio Review

Integration of Biomarkers to Inform Treatment Decisions in Breast Cancer: Progress and Pitfalls

FEATURING Aleix Prat
  • 190 views
  • February 23, 2022
21:35

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

2022 Cleveland Clinic Updates in Breast Cancer Surgery

FEATURING Julie Lang
  • 200 views
  • March 9, 2022
  • 1
46:01

University of Kansas Cancer Center Post San Antonio Review

Post SABCS Review: Q&A and Case Discussion - Gene Expression Test, ET and Local Therapy Patient Selection, PIK3CA Mutation

FEATURING Priyanka Sharma, Jennifer Klemp, Angela DeMichele, Aleix Prat, Wendy Woodward, Shane Stecklein
  • 359 views
  • February 23, 2022
06:32

ASCO 2022 Conference Coverage

ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia in mBC

FEATURING Sherry Shen
  • 357 views
  • June 8, 2022
  • 1
09:18

ASCO 2022 Conference Coverage

ASCO 2022 Survival Outcomes in Metastatic HR+, HER2- IDC Compared to ILC and Mixed Ductal/Lobular Treated With ET in Combination With CDK4/6is/mTORi/PI3Ki

FEATURING Jason Mouabbi
  • 796 views
  • June 9, 2022
  • 6
06:50

ASCO 2022 Conference Coverage

ASCO 2022 on Alpelisib + Continued ET Following Progression on ET in HR+/HER2-/PIK3CAm mBC: A Big Ten Cancer Research Consortium Study

FEATURING Cristina Truica
  • 293 views
  • June 10, 2022
  • 3
43

ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Alpelisib + Continued ET Following Progression on ET in HR+/HER2-/PIK3CAm mBC: A Big Ten Cancer Research Consortium Study

FEATURING Cristina Truica
  • 57 views
  • June 10, 2022
10:12

ASCO 2022 Conference Coverage

ASCO 2022 on FLEX - the 30,000 Breast Cancer Transcriptome Project: A Platform for Early BC Research Using Full-Genome Arrays Paired With Clinical Data

FEATURING Cynthia Ma
  • 143 views
  • June 30, 2022
52

ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on FLEX - the 30,000 Breast Cancer Transcriptome Project: A Platform for Early BC Research Using Full-Genome Arrays Paired With Clinical Data

FEATURING Cynthia Ma
  • 4 views
  • June 30, 2022
52

ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on FLEX - the 30,000 Breast Cancer Transcriptome Project: A Platform for Early BC Research Using Full-Genome Arrays Paired With Clinical Data

FEATURING Cynthia Ma
  • 4 views
  • June 30, 2022